Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Retained Earnings: 2019-2025

Historic Retained Earnings for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -$493.8 million.

  • Biodesix's Retained Earnings fell 8.70% to -$493.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$493.8 million, marking a year-over-year decrease of 8.70%. This contributed to the annual value of -$462.5 million for FY2024, which is 10.23% down from last year.
  • Per Biodesix's latest filing, its Retained Earnings stood at -$493.8 million for Q3 2025, which was down 1.80% from -$485.1 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Retained Earnings peaked at -$265.8 million during Q1 2021, and registered a low of -$493.8 million during Q3 2025.
  • For the 3-year period, Biodesix's Retained Earnings averaged around -$442.0 million, with its median value being -$444.0 million (2024).
  • Data for Biodesix's Retained Earnings shows a maximum YoY dropped of 21.67% (in 2022) over the last 5 years.
  • Over the past 5 years, Biodesix's Retained Earnings (Quarterly) stood at -$302.0 million in 2021, then declined by 21.67% to -$367.4 million in 2022, then declined by 14.19% to -$419.6 million in 2023, then fell by 10.23% to -$462.5 million in 2024, then fell by 8.70% to -$493.8 million in 2025.
  • Its last three reported values are -$493.8 million in Q3 2025, -$485.1 million for Q2 2025, and -$473.6 million during Q1 2025.